551 related articles for article (PubMed ID: 11372014)
1. Medical treatment of peripheral arterial disease and claudication.
Hiatt WR
N Engl J Med; 2001 May; 344(21):1608-21. PubMed ID: 11372014
[No Abstract] [Full Text] [Related]
2. Management of peripheral arterial disease in primary care.
Burns P; Gough S; Bradbury AW
BMJ; 2003 Mar; 326(7389):584-8. PubMed ID: 12637405
[No Abstract] [Full Text] [Related]
3. Peripheral arterial disease.
Hiatt WR; Nehler MR
Adv Intern Med; 2001; 47():89-110. PubMed ID: 11795081
[No Abstract] [Full Text] [Related]
4. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
5. Office management of peripheral arterial disease.
Aronow WS
Am J Med; 2010 Sep; 123(9):790-2. PubMed ID: 20800143
[TBL] [Abstract][Full Text] [Related]
6. Peripheral arterial disease in women.
Aronow WS
Maturitas; 2009 Dec; 64(4):204-11. PubMed ID: 19853389
[TBL] [Abstract][Full Text] [Related]
7. Optimal risk factor modification and medical management of the patient with peripheral arterial disease.
Chi YW; Jaff MR
Catheter Cardiovasc Interv; 2008 Mar; 71(4):475-89. PubMed ID: 18307227
[TBL] [Abstract][Full Text] [Related]
8. Peripheral arterial disease.
Clin Evid; 2003 Jun; (9):119-31. PubMed ID: 15366137
[No Abstract] [Full Text] [Related]
9. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
Paraskevas KI
J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
[No Abstract] [Full Text] [Related]
10. [Intermittent claudication: review of a disease of growing prevalence. II. Treatment].
Riambau V; Piñol C
Med Clin (Barc); 1998 Feb; 110(6):220-7. PubMed ID: 9580403
[No Abstract] [Full Text] [Related]
11. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
Rehring TF; Stolcpart RS; Hollis HW;
J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
[TBL] [Abstract][Full Text] [Related]
12. The importance of conservative measures in peripheral arterial disease: an update.
Paraskevas KI; Papas TT; Pavlidis P; Bessias N; Andrikopoulos V
Angiology; 2008; 59(5):529-33. PubMed ID: 18504264
[No Abstract] [Full Text] [Related]
13. Treating patients with peripheral arterial disease and claudication.
Treat-Jacobson D; Walsh ME
J Vasc Nurs; 2003 Mar; 21(1):5-14; quiz 15-6. PubMed ID: 12629492
[TBL] [Abstract][Full Text] [Related]
14. Management of peripheral arterial disease.
Aronow WS
Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
[TBL] [Abstract][Full Text] [Related]
15. Contemporary and optimal medical management of peripheral arterial disease.
Tattersall MC; Johnson HM; Mason PJ
Surg Clin North Am; 2013 Aug; 93(4):761-78, vii. PubMed ID: 23885930
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of arteriosclerosis obliterans (ASO)].
Matsuo H
Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
[TBL] [Abstract][Full Text] [Related]
17. Update on peripheral arterial disease and claudication rehabilitation.
Salameh MJ; Ratchford EV
Phys Med Rehabil Clin N Am; 2009 Nov; 20(4):627-56. PubMed ID: 19781503
[TBL] [Abstract][Full Text] [Related]
18. Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
Regensteiner JG; Stewart KJ
Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):604-10. PubMed ID: 17063165
[TBL] [Abstract][Full Text] [Related]
19. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options.
Rockson SG; Cooke JP
Adv Intern Med; 1998; 43():253-77. PubMed ID: 9506185
[No Abstract] [Full Text] [Related]
20. Peripheral arterial disease: drug therapy.
Schwartz JB
J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
